300434.SZ
Sichuan Goldstone Asia Pharmaceutical, Inc.
SZSE · Industrials · C 制造业 · CN
CNY 11.27
−4.81%Aug 3, 2026, 07:52 UTC
Zhejiang Di'er Pharmaceutical Co., Ltd.'s diclofenac sodium sustained-release tablets are provisionally selected in the 12th national centralized drug procurement; the product's 2025 sales revenue was 6.2231 million yuan, accounting for 0.60% of the company's 2025 operating revenue.
Source: